Pages that link to "Q28507076"

The following pages link to The synovial sarcoma SYT-SSX2 oncogene remodels the cytoskeleton through activation of the ephrin pathway (Q28507076):

Displaying 20 items.

• Mitogen-activated protein kinase 14 (Q15326939) (← links)
• Eph receptor B2 (Q21496072) (← links)
• Tubulin, alpha 1A (Q21498255) (← links)
• Epidermal growth factor receptor (Q21981692) (← links)
• Casein kinase 1, alpha 1 (Q21982362) (← links)
• SS18, nBAF chromatin remodeling complex subunit (Q21990645) (← links)
• Epigenetic features of human mesenchymal stem cells determine their permissiveness for induction of relevant transcriptional changes by SYT-SSX1. (Q30914150) (← links)
• The synovial sarcoma-associated SYT-SSX2 oncogene antagonizes the polycomb complex protein Bmi1. (Q33425217) (← links)
• Synovial sarcoma: from genetics to genetic-based animal modeling (Q34593303) (← links)
• Multiple receptor tyrosine kinases promote the in vitro phenotype of metastatic human osteosarcoma cell lines (Q36438319) (← links)
• Gene expression profiling for the investigation of soft tissue sarcoma pathogenesis and the identification of diagnostic, prognostic, and predictive biomarkers (Q37468623) (← links)
• Receptor tyrosine kinases in osteosarcoma: not just the usual suspects (Q38219833) (← links)
• Synovial sarcoma is a gateway to the role of chromatin remodeling in cancer (Q38567366) (← links)
• microRNA-133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway (Q39137248) (← links)
• Synovial Sarcoma: Advances in Diagnosis and Treatment Identification of New Biologic Targets to Improve Multimodal Therapy. (Q39233440) (← links)
• Reprogramming of mesenchymal stem cells by the synovial sarcoma-associated oncogene SYT-SSX2 (Q39458600) (← links)
• Comparative protein profiling of B16 mouse melanoma cells susceptible and non-susceptible to alphavirus infection: Effect of the tumor microenvironment. (Q40537831) (← links)
• Downstream and intermediate interactions of synovial sarcoma-associated fusion oncoproteins and their implication for targeted therapy (Q41918438) (← links)
• Establishment and proteomic characterization of a novel synovial sarcoma cell line, NCC-SS2-C1. (Q52601590) (← links)
• CIC-DUX4 oncoprotein drives sarcoma metastasis and tumorigenesis via distinct regulatory programs (Q92069134) (← links)